Efficacy of Enteric-Release Oral Budesonide in Treatment of Acute Reactions to Gluten in Patients With Celiac Disease.

Clin Gastroenterol Hepatol

Celiac Center, Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Celiac Research Program, Harvard Medical School, Boston, Massachusetts. Electronic address:

Published: January 2020

Celiac disease (CeD) is a common gluten-responsive T cell-mediated enteropathy. The only current treatment is gluten avoidance; however, even when attempting to adhere to a gluten-free diet (GFD), symptomatic gluten exposures are frequent..

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754800PMC
http://dx.doi.org/10.1016/j.cgh.2019.03.029DOI Listing

Publication Analysis

Top Keywords

celiac disease
8
efficacy enteric-release
4
enteric-release oral
4
oral budesonide
4
budesonide treatment
4
treatment acute
4
acute reactions
4
reactions gluten
4
gluten patients
4
patients celiac
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!